Stock Code: 30079 Bond Code: 123113 Stock Abbreviation: Xianle Health Bond Abbreviation: Xianle Convertible Bond Announcement Code: 2026-066
Xianle Health Co., Ltd. Remuneration and Assessment Committee
Audit Report on the Fulfillment of Vesting Conditions for the Second Tranche of the 2023 Restricted Stock Incentive Plan (First Grant) and the First Tranche of the 2025 Restricted Stock Incentive Plan (First Grant)
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Xianle Health Co., Ltd. (hereinafter referred to as the "Company") held the 13th meeting of the Fourth Remuneration and Assessment Committee on April 10, 2026. The meeting reviewed and approved the "Proposal on the Fulfillment of Vesting Conditions for the Second Tranche of the 2023 Restricted Stock Incentive Plan (First Grant)" and the "Proposal on the Fulfillment of Vesting Conditions for the First Tranche of the 2025 Restricted Stock Incentive Plan (First Grant)". In accordance with the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Securities Law of the People's Republic of China" (hereinafter referred to as the "Securities Law"), the "Administrative Measures for Equity Incentives of Listed Companies" (hereinafter referred to as the "Administrative Measures"), and the "Shenzhen Stock Exchange GEM Listed Company Self-Regulatory Guidelines No. 1 - Business Handling," and other relevant laws, regulations, normative documents, and the "Articles of Association" of the Company, the fulfillment of vesting conditions for the second vesting period of the 2023 Restricted Stock Incentive Plan (First Grant) and the first vesting period of the 2025 Restricted Stock Incentive Plan (First Grant) has been audited, and the audit opinion is as follows:
I. Audit Report on the Fulfillment of Vesting Conditions for the Second Tranche of the 2023 Restricted Stock Incentive Plan (First Grant)
-
The Company meets the conditions stipulated in the "Administrative Measures" and the 2023 Restricted Stock Incentive Plan and other laws, regulations, and normative documents for implementing equity incentives, possesses the qualification for implementing equity incentives, and meets the requirements for the second vesting period of the first grant of the 2023 Restricted Stock Incentive Plan. No circumstances that prohibit vesting as stipulated in the 2023 Restricted Stock Incentive Plan have occurred.
-
Upon review, the incentive recipients of the first grant of the 2023 Restricted Stock Incentive Plan do not fall into any of the following circumstances: (1) Identified as an unsuitable person by the stock exchange within the last 12 months; (2) Identified as an unsuitable person by the China Securities Regulatory Commission and its dispatched agencies within the last 12 months; (3) Subject to administrative penalties or market entry bans by the China Securities Regulatory Commission and its dispatched agencies due to major violations of laws and regulations within the last 12 months; (4) Subject to circumstances that prohibit them from serving as directors or senior management personnel of the Company as stipulated by the "Company Law"; (5) Prohibited from participating in equity incentives of listed companies by laws and regulations; (6) Other circumstances identified by the China Securities Regulatory Commission.